Infliximab dose escalation vs. initiation of adalimumab for loss of response in Crohn’s disease: a cost-effectiveness analysis

✍ Scribed by G. G. KAPLAN; C. HUR; J. KORZENIK; B. E. SANDS

• Book ID: 108605177
• Publisher: John Wiley and Sons
• Year: 2007
• Tongue: English
• Weight: 293 KB
• Volume: 26
• Category: Article
• ISSN: 0269-2813
• DOI: 10.1111/j.1365-2036.2007.03548.x